OPEN Health merges with Medical Communications Services Provider Peloton Advantage

Written by David Rowley on Tuesday 4th December 2018

OPEN Health merges with Medical Communications Services Provider Peloton Advantage

Transaction brings together complementary capabilities to create leading global health communications and market access group

LONDON – (December 4th, 2018) – OPEN Health Communications LLP (“OPEN Health”), a multi-disciplinary health communications and market access group, announced today that it has successfully completed a merger with Peloton Advantage (“Peloton”), a leading provider of medical communications services to Medical Affairs departments at pharmaceutical, biotechnology, and medical device companies. Peloton is a portfolio investment of Amulet Capital Partners (“Amulet”), a private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Terms of the transaction were not disclosed.

The combined entity will operate in 7 locations across 3 continents, with approximately 520 employees. Current OPEN Health CEO David Rowley will continue to serve as the company’s CEO and will be supported on the executive team by Sandy Royden, Co-Founder of OPEN Health, and Carolyn S. Clark, MBA, and Michael J. McLaughlin, MD, Co-Founders of Peloton Advantage.

The new entity works with 90% of the world’s top 40 pharmaceutical companies, with a broad client base in biotechnology and medical device companies. The combined business will have extensive practices in the following areas:

  • Medical Communications and Publication Planning
  • Value, Informatics and Evidence
  • Patient and Brand Communications
  • Consulting and Commercialisation

David Rowley, OPEN Health Group CEO said, “The merger of Peloton and OPEN Health provides very strong strategic, geographic, therapeutic and management synergies. Both teams believe that as a combined entity we can provide a wider range of services to our current clients, as well as allowing for geographic expansion of core specialisms on both sides of the Atlantic and beyond. We are very excited to be starting this new chapter in our corporate history with the founders of both businesses committed to a strong future together.”

Carolyn S. Clark, MBA, Co-Founder of Peloton said, “We have known David and the OPEN Health team for some time and are excited to work alongside them to create the medical communication industry's most unique and complete platform. We see strong similarities in our approaches to client service and account management, as well as in recruiting and retaining high quality, highly expert staff, which is ultimately the core differentiator for our clients. Our combined synergistic therapeutic and geographic footprint will benefit our customers, our employees, our partners and the communities that we serve.”

Ramsey Frank, Partner and Co-Founder of Amulet added, “This merger creates a unique platform and reach to globally serve biopharmaceutical clients across a range of medical affairs, commercial, HEOR, real-world evidence and market access functions. The talent of both organisations is reflected in the management team, which provides an excellent blend of expertise from both companies. We are excited for the potential offered by the combined business.”

About OPEN Health Communications LLP 

OPEN Health is a multi-disciplinary health communications and market access group, operating within four core business areas: Medical Communications; Patient and Brand Communications; Value, Informatics and Evidence; Consulting and Commercialisation. OPEN Health was formed in 2011 as a joint venture with Chime Communications, and whilst working across a broad therapeutic range has a strong focus on oncology, rare diseases and specialist medicines. For more information on OPEN Health, please visit 

About Peloton Advantage, LLC 

Peloton Advantage, LLC is a privately owned medical communications company specialising in strategic publication planning and associated content development for medical education programs. Peloton’s teams support US and global accounts for large and small pharmaceutical, biotechnology, and medical device companies, contributing to the success of more than 90 products spanning all major therapeutic areas. For more information on Peloton Advantage, please visit 

About Amulet Capital Partners, LP 

Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. Amulet Capital Partners’ investment team has approximately 50 years of private equity experience. For additional information, please visit 


OPEN Health: David Rowley;
+44 1628 481112 

Peloton: Carolyn Clark;
+1 973 582 5701

For Amulet Capital Partners: Melissa Sheer;
+1 917 690 2199